World's Best Scientists 2026 revealed!
Therapeutics and Clinical Risk Management
H-index 16

Therapeutics and Clinical Risk Management

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1991 31 31 13

Additional Metrics

Number of Best Scientists*: 73
Documents by Best Scientists*: 68
Top 100 Ranked Scientists*: 1
SCIMAGO H-index: 74
SCIMAGO SJR: 0.699
Impact Factor: 2.2

Overview

Top Research Topics at Therapeutics and Clinical Risk Management?

Therapeutics and Clinical Risk Management generally zeroes in on subjects such as Internal medicine, Surgery, Intensive care medicine, Disease and Pharmacology. Issues in Internal medicine were discussed, taking into consideration concepts from other disciplines like Gastroenterology, Oncology and Cardiology. The featured Disease study falls within the wider topic of Pathology.

Tolerability and Drug are all topics related to Pharmacology research discussed.

  • Internal medicine (40.01%)
  • Surgery (16.88%)
  • Intensive care medicine (10.64%)

What are the most cited papers published in the journal?

  • Factors affecting therapeutic compliance: A review from the patient's perspective. (737 citations)
  • The challenge of patient adherence (624 citations)
  • Epidemiology and risk factors for invasive candidiasis (348 citations)

Research areas of the most cited articles at Therapeutics and Clinical Risk Management:

The published papers are mainly concerned with subjects like Internal medicine, Pharmacology, Intensive care medicine, Disease and Surgery. The study of Internal medicine in the most cited papers encompasses disciplines such as Oncology, as well as fields such as Chemotherapy, all of which overlap with one another. The published papers with studies in Surgery featured incorporate elements of Anesthesia and Osteoporosis.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Surgery
  • Disease

The previous edition focused in particular on these issues:

Therapeutics and Clinical Risk Management mainly deals with areas of study such as Internal medicine, Retrospective cohort study, Gastroenterology, Adverse effect and Surgery. Oncology and Cardiology are some topics wherein Internal medicine research discussed in Therapeutics and Clinical Risk Management have an impact. Research in Cohort and the interrelating topic of Risk factor were among the subjects of interest in the Retrospective cohort study studies discussed in the journal.

The journal explores topics in Adverse effect which can be helpful for research in disciplines like Cancer, Off-label use, Adverse drug reaction, Randomized controlled trial and Intensive care medicine. While the primary focus in the journal is Randomized controlled trial, it also dissects topics surrounding Placebo and Clinical trial as a whole. The journal facilitates discussions in Perioperative and Complication as part of the larger field of Surgery, however, it also tackles fields such as In patient.

The most cited articles from the last journal are:

  • Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review (10 citations)
  • Emerging B-Cell Therapies in Systemic Lupus Erythematosus. (6 citations)
  • Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Therapeutics and Clinical Risk Management (based on the number of publications) are:

  • Yukio Nakamura (13 papers) published 2 papers at the last edition,
  • Jun Iwamoto (13 papers) absent at the last edition,
  • Yoshihiro Sato (12 papers) absent at the last edition,
  • Hiroyuki Kato (12 papers) published 1 paper at the last edition,
  • Hideo Matsumoto (10 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Therapeutics and Clinical Risk Management (based on the number of publications) are:

  • Zhejiang University (48 papers) published 1 paper at the last edition, 2 less than at the previous edition,
  • Sun Yat-sen University (35 papers) published 3 papers at the last edition the same number as at the previous edition,
  • Capital Medical University (30 papers) published 2 papers at the last edition the same number as at the previous edition,
  • Memorial Hospital of South Bend (28 papers) published 1 paper at the last edition,
  • Boston Children's Hospital (24 papers) published 1 paper at the last edition, 2 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 21.62% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 19.54% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.20% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.39% of all publications and 52.87% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Therapeutics and Clinical Risk Management

Another topic of interest in the realm of Therapeutics and Clinical Risk Management is related to the career opportunities for research enthusiasts in this field. Researchers can take advantage of several opportunities in Academia, Pharmaceutical companies, Clinical settings, or Non-Profit health organizations where contributions can significantly impact the development of new therapies and risk management processes. A common pathway includes becoming a registered nurse with a specialization in a discipline such as Oncology, Anesthesia, or Intensive care. The path to this career is quite straightforward as detailed in this resource on how to become a registered nurse in Hawaii. The nursing profession provides a pivotal role in the application of clinical therapeutics and risk management. A nurse is often at the forefront of administering therapeutics and has a concerning interest in minimizing clinical risk. Another career pathway in this field is becoming a Research Scientist. Typically, this involves conducting investigations on the effectiveness of certain therapeutics while also considering the associated clinical risks. A Research Scientist would usually have a strong background in Pharmacology, Pathology, or a related biomedical science discipline. Not only limited to the mentioned roles, but there are also various other designations which individuals can explore such as Clinical Pharmacologist, Therapeutic Risk Manager, Medical Writer, and many more. All these roles play a significant part in advancing the field of Therapeutics and Clinical Risk Management, adding an inclusive value to the overall healthcare system.

Top Publications

  • Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review

    John A Glaspy;Michelle Z Lim-Watson;Michael A Libre;Swagata S Karkare

    (2020)
    65 Citations
  • Refractory Sarcoidosis: A Review.

    Thomas El Jammal;Yvan Jamilloux;Mathieu Gerfaud-Valentin;Dominique Valeyre

    (2020)
    52 Citations
  • Diagnosis and Screening of Patients with Fabry Disease

    Irfan Vardarli;Christoph Rischpler;Ken Herrmann;Frank Weidemann

    (2020)
    46 Citations
  • Prevention and Treatment of Postoperative Nausea and Vomiting (PONV): A Review of Current Recommendations and Emerging Therapies

    Zhaosheng Jin;Tong J Gan;Sergio D Bergese

    (2020)
    40 Citations
  • Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date

    Jean Kim;Robert Naclerio

    (2020)
    33 Citations
  • Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects

    (2023)
    27 Citations
  • Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges.

    Celina Dubin;Ester Del Duca;Emma Guttman-Yassky;Emma Guttman-Yassky

    (2020)
    27 Citations
  • Tildrakizumab: An Evidence-Based Review of Its Use in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis

    Charlotte Näslund-Koch;Claus Zachariae;Claus Zachariae;Lone Skov;Lone Skov

    (2020)
    17 Citations
  • Octreotide-Resistant Acromegaly: Challenges and Solutions

    Giuliana Corica;Marco Ceraudo;Claudia Campana;Federica Nista

    (2020)
    17 Citations
  • Gene Therapy for Overactive Bladder: A Review of BK-Channel α-Subunit Gene Transfer

    Karl Erik Andersson;George Joseph Christ;Kelvin P. Davies;Eric S. Rovner

    (2021)
    16 Citations

Related Online Degrees & Career Pathways

For individuals interested in healthcare but not pursuing a traditional medical degree, online programs offer diverse career pathways. Careers in medical coding and billing are gaining traction due to the growing demand for accurate health information management. Understanding the medical coding salary helps prospective students evaluate the financial benefits of entering this field.

Exploring the medical billing and coding job outlook reveals a stable and promising career trajectory, making it an attractive option for those seeking flexibility and growth in healthcare administration roles.

For those interested in advancing into healthcare leadership and data management, enrolling in one of the affordable online HIM programs can provide essential skills in information management and compliance.

Another complementary pathway is nutrition, which plays a pivotal role in patient care and preventive health. Students can consider pursuing the cheapest online nutrition degree to bolster their expertise and open doors to numerous allied health career options.

Best Scientists Contributing to This Journal

Recently Published Articles